CUREVAC N V's ticker is and the CUSIP is N2451R905. A total of 4 filers reported holding CUREVAC N V in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,021,085 | +46.5% | 149,500 | +123.5% | 0.00% | +50.0% |
| Q2 2023 | $697,098 | +325.6% | 66,900 | +184.7% | 0.00% | +100.0% |
| Q1 2023 | $163,795 | -41.2% | 23,500 | -49.1% | 0.00% | 0.0% |
| Q4 2022 | $278,586 | +15.6% | 46,200 | +51.0% | 0.00% | – |
| Q3 2022 | $241,000 | -88.8% | 30,600 | -80.7% | 0.00% | -100.0% |
| Q2 2022 | $2,154,000 | +18.4% | 158,300 | +70.6% | 0.00% | +50.0% |
| Q1 2022 | $1,820,000 | -65.3% | 92,800 | -39.2% | 0.00% | -50.0% |
| Q4 2021 | $5,239,000 | -71.3% | 152,700 | -54.3% | 0.00% | -80.0% |
| Q3 2021 | $18,238,000 | -54.9% | 333,900 | -39.4% | 0.02% | -59.2% |
| Q2 2021 | $40,465,000 | +41.3% | 550,700 | +75.8% | 0.05% | +16.7% |
| Q1 2021 | $28,645,000 | +924.1% | 313,200 | +807.8% | 0.04% | +740.0% |
| Q4 2020 | $2,797,000 | +955.5% | 34,500 | +505.3% | 0.01% | +400.0% |
| Q3 2020 | $265,000 | – | 5,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 34,500 | $2,797,000 | 0.01% |
| JPMORGAN CHASE & CO | 40,000 | $3,243,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 439 | $0 | 0.00% |